tirzepatide is generic for what drug 🚨 Versions of Mounjaro & Zepbound Move Closer as FDA Reviews First Applications The US Food and Administration (FDA) reviewing the first applications generic versions of Eli Lilly's is tirzepatide a generic drug

Low cardiac content of long-chain acylcarnitines in TMLHE knockout mice prevents ischaemia-reperfusion-induced mitochondrial and cardiac damage

Studies have also linked B12 deficiency to non-alcoholic fatty liver disease and altered lipid metabolism

Median direct R&D cost: $150 million (median: the value that falls exactly in the middle when all values in a dataset are arranged from smallest to largest) Average direct R&D cost: $369 million After adjustments (for opportunity costs and drugs that did not reach the market): Median: $708 million, Average: $1.3 billion When only two extremely costly drugs are excluded, the average cost drops to $950 million (26% lower)

Very few state Medicaid programs cover Zepbound (tirzepatide for weight loss) as of April 2026

Patients should discuss dose measurement with their provider or compounder